Broad spectrum of congenital chest wall deformities exists. More frequent ones are pectus excavatum and carinatum. Aim of this study to evaluate co-existing cardiac pathologies and define strategy in investigating young patients with chest wall deformities.
We analyzed patients with anterior chest wall deformity including additional symptoms applied to our military hospital between September –November 2008 . Medical history and symptoms were questioned, multisystem physical examination were done, posteroanterior and lateral chest X-ray, electrocardiogram (ECG ), Echocardiography were performed.
There were 33 male patients with mean age 21.1(19–28) . There were 19 Pectus excavatum, 12 pectus carinatum, 2 combined deformites . Symptoms of the patients were : 19 had chest pain, 26 dyspnea, 23 palpitation. There were 9 (27.3% of 33 ) patients, whom had symptoms, with pathologic ECG findings; 5 right incomplete bundle block, 2 right anterior fascicule block , 1 right axis deviation , 1 left ventricular hypertrophy and right incomplete bundle block. Four of them ( 12.1 % of 33 ) had pathological echocardiolography findings; 1 patient with pectus carinatum had minimal aortic valve insuffiency and minimal mitral valve insufficiency , 2 patients with pectus excavatum had minimal mitral valve prolapsus and minimal mitral valve insuffiency ,1 patient with combined anterior chest wall deformity had mitral valve prolapsus with third degree mitral valve insuffiency. He had multi system problems .He was decided as not in good health for the military service and referred to detailed genetic investigations and surgical repair . Three patients were put on follow up without any treatment .
Patients with anterior chest wall deformities may have accompanying cardiac pathologies.
Rather than routine investigations symptomatic patients with physical examination findings should be evaluated including ECG and echocardiography to document and plan a follow-up for any possible anatomic and conduction pathology of the heart.
Volkan Kara, No Financial Disclosure Information; No Product/Research Disclosure Information